Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
74 hedge funds and large institutions have $58.3M invested in Genesis Healthcare, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 9 closing their positions.
4,500% more call options, than puts
Call options by funds: $46K | Put options by funds: $1K
94% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 18
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% less funds holding
Funds holding: 77 → 74 (-3)
23% less capital invested
Capital invested by funds: $76.1M → $58.3M (-$17.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.13M |
| 2 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$5.3M |
| 3 |
JP Morgan Chase
New York
|
+$3.07M |
| 4 |
Renaissance Technologies
New York
|
+$1.33M |
| 5 |
FWC
First Washington Corp
Seattle,
Washington
|
+$718K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$305K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$194K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$133K |
| 4 |
Citigroup
New York
|
-$132K |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$117K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$133K | -36,967 | Closed |
|
|
TCM
77
Teza Capital Management
Chicago,
Illinois
| – | -$65K | -15,308 | Closed |
|
78
SG Americas Securities
New York
| – | -$57K | -13,361 | Closed |
|
|
ARTA
79
A.R.T. Advisors
New York
| – | -$49K | -11,734 | Closed |
|
|
RFC
80
Regions Financial Corp
Birmingham,
Alabama
| – | -$43K | -10,000 | Closed |
|
|
TRCT
81
Tower Research Capital (TRC)
New York
| – | -$37K | -8,706 | Closed |
|
82
Walleye Trading
New York
| – | -$22K | -5,100 | Closed |
|
83
Group One Trading
Chicago,
Illinois
| – | -$11K | -2,600 | Closed |
|
GEN Hedge Fund Activity: Q1 2017 in Review
74 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2017, worth a combined $58.3M — down 23% from $76.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GEN positions and 9 closed out — a net gain of 2 holders — while 35 added to existing stakes and 18 trimmed.
The largest buyer was BlackRock, adding an estimated $8.13M. The largest seller was Wells Fargo, cutting an estimated $305K.
- 74 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2017, down from 77 in Q4 2016.
- Funds reported $58.3M of Genesis Healthcare, Inc. stock for Q1 2017, down 23% quarter-over-quarter.
- 11 funds opened new Genesis Healthcare, Inc. positions in Q1 2017 and 9 closed out, a net change of +2 holders.
- The largest Genesis Healthcare, Inc. buyer in Q1 2017 was BlackRock, an estimated $8.13M added.
- The largest Genesis Healthcare, Inc. seller in Q1 2017 was Wells Fargo, an estimated $305K sold.
Based on aggregated 13F filings for Q1 2017.